CancerNetwork Members: Login | Register
CancerNetwork SearchMedica Medline Drugs

Powered by SearchMedica

 
PUBLICATIONS
NEWS
PODCASTS
TOPICS
BLOGS
PATIENTS
NURSES
JOBS
CONFERENCES
CME
SUPPLEMENTS
 

Home » Palliative and Supportive Care

ONCOLOGY. Vol. 24 No. 4
Research Reports
 

Breakthrough Cancer Pain Is Top Challenge for Cancer Patients, Even When Using Pain Treatments, New Survey Reveals

April 9, 2010

A survey recently released by the American Pain Foundation (APF) reveals that breakthrough cancer pain is one of the most challenging aspects of having cancer, according to 75% of US adults who have ever been diagnosed with cancer and experience this type of pain. The survey also found that breakthrough cancer pain negatively impacts quality of life, contributes to additional financial hardships, and can interfere with one’s ability to cope with other aspects of cancer treatment.

Restoring Quality of Life

“We’re not talking about minor aches and pains,” said Will Rowe, APF’s chief executive officer. “These severe flares of pain often strike without warning, leaving many people fearful of the next crippling episode and unduly burdening patients and their families. Effective pain management is critical to restoring the quality of life these individuals so rightfully deserve.”

More than half of those surveyed (53%) rated their pain an 8, 9, or 10 out of 10, with 10 being the worst pain imaginable. While 44% said their pain is not adequately controlled, a vast majority (91%) believe their quality of life would “greatly improve” if they could get their breakthrough cancer pain under control.

The survey, commissioned by APF and conducted online by Harris Interactive, is the first to explore the impact breakthrough cancer pain has on a patient’s quality of life, medical treatment, and finances among adults who have been diagnosed with cancer, are currently living with cancer-related pain, are taking medication to manage the pain, and experience sudden, temporary pain flares.

According to the survey:

• 73% said breakthrough cancer pain wakes them from a deep sleep at least once a month

• 76% reported that breakthrough pain affects their ability to perform everyday household chores

• 83% indicated that breakthrough cancer pain affects their desire to participate in certain activities.

Breakthrough Cancer Pain Needs More Attention

The vast majority (95%) of those who currently see a health-care provider for their cancer or cancer pain have discussed breakthrough cancer pain with their health-care provider at some point. Incidentally, more than half (52%) said their health-care provider has described breakthrough cancer pain as a normal side effect of cancer or its treatment.

“The phenomenon of breakthrough cancer pain presents a challenge for patients and their health-care providers because it occurs even when a patient is taking the right dose of medication on a regular basis,” said Russell K. Portenoy, MD, Chairman of the Department of Pain Medicine and Palliative Care at Beth Israel Medical Center and member of the board of directors for APF. “Providers and patients should not accept breakthrough cancer pain as a normal side effect of cancer. More studies are needed to determine the most effective treatments to alleviate this pain.”

 

Join the Conversation

Want to join the conversation? If you're a healthcare professional, we'd like to hear your comments. Just sign in or register today to become part of our growing, online community.

  • Oldest First
  • Newest First

by Sarah Dees | April 16, 2010 11:34 AM EDT

Doctors need to understand the impact of breakthrough pain and do more to help cancer patients with this aspect of treatment. My meds were prescribed by my neurologist during cancer treatment, not my oncologists. The oncologists were very stingy with prescribing pain meds, while my neurologist did not hesitate to give me what I needed to be comfortable. While I was in chemo treatments and radiation, I would be using the Actiq lozenges or "lollipops"to control breakthrough pain. Many other cancer patients asked me, "What is that?" I told them what it was, and what it was for. None of them had been offered the medication by their doctors. I told them to ask for the medicine, that they were entitled to have enough pain medication to cover their breakthrough pain. They would go back to their doctors and ask for it, then begin to use it. Why wasn't this offered to them in the first place? Why do patients have to learn about pain meds for breakthrough pain from another patient, instead of being made aware of all options available to them from the start by their own doctors?

As a side note, I want to mention that doctors worry too much about the "addictive effects" of these medicines. When I didn't need them any more, I just stopped using them, weaning off gradually. Cancer patients aren't drug seekers or junkies. They shouldn't be made to suffer more than they already do. Patients need the medication to get through the black days of this treatment, and when it's over, then address weaning off the meds at the appropriate times. Living in pain is far worse than worrying about any future possible addiction problems that haven't even come up yet.






 
TOPIC INDEX

  • Bladder Cancer
  • Bone Metastases
  • Breast Cancer
  • CML
  • Colorectal Cancer
  • End-of-Life
  • GIST
  • Genetics Genomics
  • Gynecologic Cancers
  • Head & Neck Cancer
  • Integrative Oncology
  • Leukemia
  • Lung Cancer
  • Lymphoma
  • Melanoma
  • Multiple Myeloma
  • Nausea & Vomiting
  • Palliative Care
  • Pancreatic Cancer
  • Practice Management
  • Practice & Policy
  • Prostate Cancer
  • RCC
  • Skin Cancer
  • Triple-Negative Breast
  • Testicular Cancer


More Topics 


 
   SEARCH MEDICA RX
   Browse drugs by name:
A B C D E F G H I J
K L M N O P Q R S T
U V W X Y Z All      
   Search for drugs:
Search

 

 
FROM PHYSICIANS PRACTICE
Tax Schemes Every Physician Should Avoid
Ike Devji, JD, January 31, 2012
The next 60 days marks the final push to sell physicians across the United States tax plans of both good and questionable value.
Boosting Collections at Your Medical Practice: Whose Job Is It?
P.J. Cloud-Moulds, January 28, 2012
Embrace the relationship between your billing company and your medical practice staff.
Managing Difficult Medical Practice Employees
Shelly K. Schwartz, January 27, 2012
Tips for transforming immature staff members into great employees.
Prevent Physician Distraction When Using mHealth Technology
Aubrey Westgate, January 25, 2012
As more and more physicians use handheld mobile technology in their day-to-day work, some critics are raising concerns about “distracted doctoring.”
Can That Applicant Do the Job at Your Medical Practice?
Karen Zupko, January 25, 2012
If like many communities, yours has significant numbers of non-English speaking people with whom neither you nor your staff are able to converse, your practice is at a serious disadvantage.
 
MOST POPULAR
  • Most Popular
  • Most Emailed
  • Most Recent
  • Head and Neck Tumors
  • 46-Year-Old Woman Presents With Difficulty in Ambulation, and Swelling and Discoloration of Both Eyelids
  • Optimizing Outcomes of Advanced Prostate Cancer: Drug Sequencing and Novel Therapeutic Approaches
  • A 28-Year-Old Woman Presents With a Long-Standing History of Intermittently Painful “Bumps” on Both Her Shoulders and Upper Back
  • Controversies in Oncologist-Patient Communication: A Nuanced Approach to Autonomy, Culture, and Paternalism
  • Evolution of Treatment Options for Patients With CRPC and Bone Metastases: Bone-Targeted Agents That Go Beyond Palliation of Symptoms to Improve Overall Survival
  • Ending the Shortage of Generic Oncology Drugs
  • Processed and Red Meat Consumption Linked to Slight Increase in Risk of Pancreatic Cancer
  • New Mutation May Act as Driver in Subset of Lung Cancer Patients
  • Could Aspirin Be a Viable Adjuvant Treatment for Cancer?
  • Advances and New Research in the Treatment of Kidney Cancer
  • New Way to Predict Prostate Cancer Severity—Size of Prostate
  • Vismodegib Granted FDA Approval for Treatment of Basal Cell Carcinoma
  • FDA Grants Approval to Axitinib for the Treatment of Advanced Renal Cell Carcinoma
  • Why BRAF-Mutated Colorectal Cancers Don't Respond to BRAF Inhibitors
Click here to subscribe to our newsletter
 
COMMENTS
  • Most Commented
  • Most Recent
  • When to Treat Myelodysplastic Syndromes
  • Are We Ready for Neoadjuvant Therapy in Potentially Resectable Pancreatic Cancer?
  • ASCO 2011: A Paradigm Shift in the Treatment of Endometrial Cancer
  • PSA Screening for Prostate Cancer Put Into Question By the U.S. Preventive Services Task Force
  • When to Treat Myelodysplastic Syndromes
  • ASCO 2011: A Paradigm Shift in the Treatment of Endometrial Cancer
  • Are We Ready for Neoadjuvant Therapy in Potentially Resectable Pancreatic Cancer?
  • Evolving Therapeutic Paradigms for Advanced Prostate Cancer
Click here to subscribe to our newsletter
 
JOB LISTINGS

Post a job

Powered by SearchMedica Jobs


 
SearchMedica Search Result

Find peer-reviewed literature and websites for practicing medical professionals

CME on Palliative And Supportive Care
Evidence on Palliative And Supportive Care
Guidelines on Palliative And Supportive Care
Patient Education on Palliative And Supportive Care
Clinical Trials on Palliative And Supportive Care
Practical Articles on Palliative And Supportive Care
Research and Reviews on Palliative And Supportive Care
All "Palliative And Supportive Care" results



CancerNetwork on Facebook

 

CancerNetwork | CME LLC | ConsultantLive | Diagnostic Imaging | Musculoskeletal Network | OBGYN.net | PediatricsConsultantLive |
Physicians Practice | Psychiatric Times | SearchMedica | Medical Resources

© 1996 - 2012 UBM Medica LLC, a UBM company
Privacy Statement - Terms of Service - Advertising Information - Editorial Policy Statement - UBM Medica Network Privacy Policy